Trousseau's syndrome
- PMID: 1894485
Trousseau's syndrome
Abstract
Trousseau's syndrome remains a widely unrecognized and untreated complication of cancer. The clinical spectrum of the coagulopathy extends from uncomplicated superficial thrombophlebitis to life threatening DIC. Due to the absence of specific biochemical markers associated with the hypercoagulable state, this diagnosis is often overlooked. Initial intravenous heparin followed by the chronic administration of subcutaneous heparin will usually prevent thromboembolic recurrence.
Similar articles
-
Trousseau's syndrome.Am Fam Physician. 1988 Sep;38(3):195-201. Am Fam Physician. 1988. PMID: 3046272 Review.
-
Continuous subcutaneous heparin infusion for treatment of Trousseau's syndrome.Ann Pharmacother. 1995 Jul-Aug;29(7-8):710-3. doi: 10.1177/106002809502907-812. Ann Pharmacother. 1995. PMID: 8520087
-
Low-molecular-weight heparin in the management of Trousseau's syndrome.Cancer. 1997 Aug 15;80(4):649-55. Cancer. 1997. PMID: 9264346
-
Recurrent ischemic stroke as an initial manifestation of an concealed pancreatic adenocarcinoma: Trousseau's syndrome.Chin Med J (Engl). 2011 Feb;124(4):637-40. Chin Med J (Engl). 2011. PMID: 21362297
-
Coagulopathy in prostate cancer.Neth J Med. 2003 Nov;61(11):347-54. Neth J Med. 2003. PMID: 14768717 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical